Tuesday - July 14, 2026

Category Archives: Science

Diabetic Macular Edema Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Diabetic Macular Edema Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Wearable Medical Devices Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight

The latest market forecast report provides an in-depth analysis of the Wearable Medical Devices Market, offering comprehensive insights into the market revenue trends, segmentation, and technology landscape. The report delves into key Wearable Medical Devices Market statistics, highlighting the current … Continue reading →

Guillain-Barré Syndrome Market is Projected to Witness Significant Growth by 2036 Owing to Advancements in Targeted Immunotherapies and Emerging Disease-Modifying Treatments | DelveInsight

The Guillain-Barré Syndrome Market is anticipated to witness substantial growth during the forecast period, driven by the growing awareness and early diagnosis, advancements in supportive care, and the development of targeted immunotherapies. The emergence of promising therapies such as Tanruprubart, … Continue reading →

Type 1 Diabetes Market is Projected to Witness Significant Growth by 2034 Owing to Advancements in Cell Therapies and Emerging Disease-Modifying Treatments | DelveInsight

The Type 1 Diabetes Market is anticipated to witness substantial growth during the forecast period, growing adoption of advanced insulin therapies, continuous advancements in cell and regenerative medicine, and the development of disease-modifying therapies. The emergence of innovative therapies such … Continue reading →

Meningioma Market is Projected to Witness Steady Growth by 2036 Owing to Advancements in Diagnostic Technologies and Emerging Systemic Therapies | DelveInsight

The Meningioma Market is anticipated to experience steady growth during the forecast period, driven by the increasing diagnosed patient population, continuous advancements in neuroimaging technologies, rising incidence of recurrent and high-grade meningiomas, and growing research focused on targeted and investigational … Continue reading →

Chondrosarcoma Pipeline Expands as 15+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Chondrosarcoma Pipeline Insight 2026” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Chondrosarcoma pipeline landscape. It covers the Chondrosarcoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chondrosarcoma pipeline … Continue reading →

Celiac Disease Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Celiac Disease Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Celiac Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Celiac Disease … Continue reading →

Epilepsy Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Epilepsy Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline landscape. It covers the Epilepsy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Epilepsy pipeline … Continue reading →

Food Allergy Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Food Allergy Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Food Allergy pipeline landscape. It covers the Food Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Major Depressive Disorder Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Major Depressive Disorder Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →